{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:39:33Z","timestamp":1783823973589,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 0914"],"award-info":[{"award-number":["PICT 0914"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2010-0853"],"award-info":[{"award-number":["PICT 2010-0853"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","award":["PIP 1007"],"award-info":[{"award-number":["PIP 1007"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT 20020100100522"],"award-info":[{"award-number":["UBACYT 20020100100522"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Massone S.A."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.steroids.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T23:02:23Z","timestamp":1473721343000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis"],"prefix":"10.1016","volume":"115","author":[{"given":"Flavia M.","family":"Michelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Gabriela","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Alch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2016.09.001_b0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphys.2013.00159","article-title":"Macrophages and chemokines as mediators of angiogenesis","volume":"4","author":"Owen","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.steroids.2016.09.001_b0010","doi-asserted-by":"crossref","first-page":"127170","DOI":"10.1155\/2013\/127170","article-title":"Angiogenesis and its therapeutic opportunities","volume":"2013","author":"Yoo","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.steroids.2016.09.001_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.steroids.2016.09.001_b0020","first-page":"393","article-title":"Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy","volume":"5","author":"Chen","year":"2013","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.steroids.2016.09.001_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","article-title":"The crucial role of vascular permeability factor\/vascular endothelial growth factor in angiogenesis: a historical review","volume":"128","author":"Ribatti","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.steroids.2016.09.001_b0030","doi-asserted-by":"crossref","first-page":"006593","DOI":"10.1101\/cshperspect.a006593","article-title":"The VEGF pathway in cancer and disease: responses, resistance, and the path forward","volume":"2","author":"Kieran","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.steroids.2016.09.001_b0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.leukres.2012.02.003","article-title":"Angiogenic activity of classical hematopoietic cytokines","volume":"36","author":"Ribatti","year":"2012","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2012.07.002","article-title":"Pathogenesis of herpes stromal keratitis\u2013a focus on corneal neovascularization","volume":"33","author":"Gimenez","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.steroids.2016.09.001_b0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","article-title":"Herpes simplex keratitis","volume":"25","author":"Kaye","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.steroids.2016.09.001_b0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijantimicag.2006.11.005","article-title":"Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells","volume":"29","author":"Romanutti","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.steroids.2016.09.001_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2005.07.007","article-title":"Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication","volume":"68","author":"Castilla","year":"2005","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.steroids.2016.09.001_b0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2003.10.002","article-title":"Antiherpetic mode of action of (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one in vitro","volume":"23","author":"Wachsman","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/095632020201300105","article-title":"Antiviral activity of brassinosteroids derivatives against measles virus in cell cultures","volume":"13","author":"Wachsman","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"issue":"8","key":"10.1016\/j.steroids.2016.09.001_b0070","first-page":"434","article-title":"Structure-activity relationship studies in a set of new brassinosteroid derivatives assayed against herpes simplex virus type 1 and 2 in cell cultures","volume":"11","author":"Talarico","year":"2002","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/095632020001100107","article-title":"Antiviral effect of brassinosteroids against herpes virus and arenaviruses","volume":"11","author":"Wachsman","year":"2000","journal-title":"Antivir. Chem. Chemother."},{"issue":"11\u201312","key":"10.1016\/j.steroids.2016.09.001_b0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.steroids.2004.04.011","article-title":"In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues","volume":"69","author":"Michelini","year":"2004","journal-title":"Steroids"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2016.09.001_b0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jsbmb.2007.10.002","article-title":"The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice","volume":"108","author":"Michelini","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2016.09.001_b0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bmc.2012.10.054","article-title":"Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog","volume":"21","author":"Michelini","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2016.09.001_b0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2008.05.005","article-title":"Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives","volume":"111","author":"Michelini","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2016.09.001_b0100","unstructured":"J.A. Ram\u00edrez, A. Berra, F. Michelini, L. Galagovsky, L. Alch\u00e9. A compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivities and herpetic stromal keratitis. US Patent N\u00b0 8431554, 2013."},{"issue":"13","key":"10.1016\/j.steroids.2016.09.001_b0105","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.steroids.2012.08.011","article-title":"Brassinosteroids inhibit in vitro angiogenesis in human endothelial cells","volume":"77","author":"R\u00e1rov\u00e1","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2016.09.001_b0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/B:AGEN.0000037329.45326.a8","article-title":"Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines","volume":"7","author":"Davel","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.steroids.2016.09.001_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-8871-3_1","article-title":"Vasculogenesis and angiogenesis","volume":"117","author":"Patan","year":"2004","journal-title":"Cancer Treat. Res."},{"issue":"7070","key":"10.1016\/j.steroids.2016.09.001_b0125","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.steroids.2016.09.001_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cytogfr.2014.07.009","article-title":"The multifaceted activity of VEGF in angiogenesis \u2013 implications for therapy responses","volume":"25","author":"Moens","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.steroids.2016.09.001_b0135","first-page":"163","article-title":"Antiviral activity of natural and synthetic brassinosteroids","volume":"3","author":"Wachsman","year":"2004","journal-title":"Curr. Med. Chem.: Anti-Infect. Agents"},{"key":"10.1016\/j.steroids.2016.09.001_b0140","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1016\/j.bmc.2007.09.012","article-title":"Syntheses of immunomodulating androstanes and stigmastanes: comparison of their TNF-\u03b1 inhibitory activity","volume":"15","author":"Ram\u00edrez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"1 Pt A","key":"10.1016\/j.steroids.2016.09.001_b0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbagen.2015.10.024","article-title":"Synthetic stigmastanes with dual antiherpetic and immunomodulating activities inhibit ERK and Akt signaling pathways without binding to glucocorticoid receptors","volume":"1860","author":"Michelini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.steroids.2016.09.001_b0150","unstructured":"J.A. Ram\u00edrez, A. Berra, F.M. Michelini, L.R. Galagovsky, L.E. Alch\u00e9, Antiangiogenic brassinosteroid compounds. US Patent N\u00b0 9187518 B2, 2015."},{"issue":"4","key":"10.1016\/j.steroids.2016.09.001_b0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ICO.0000000000000336","article-title":"Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits","volume":"34","author":"Park","year":"2015","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.steroids.2016.09.001_b0160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","article-title":"Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis","volume":"247","author":"Saravia","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2012.07.002","article-title":"Pathogenesis of herpes stromal keratitis \u2013 a focus on corneal neovascularization","volume":"33","author":"Gim\u00e9nez","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.steroids.2016.09.001_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800908783497122","article-title":"AKT signaling in regulating angiogenesis","volume":"8","author":"Jiang","year":"2008","journal-title":"Curr. Cancer Drug Targets"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X16301167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X16301167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T11:54:02Z","timestamp":1568375642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X16301167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"alternative-id":["S0039128X16301167"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2016.09.001","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}